Altimmune to report fourth quarter and full year 2022 financial results and provide business update on february 28, 2023

Gaithersburg, md., feb. 21, 2023 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its fourth quarter and full year 2022 financial results on tuesday, february 28, 2023 and will provide a business update.

ALT Ratings Summary

ALT Quant Ranking